DrugPatentWatch Database Preview
Lab Hra Pharma Company Profile
What is the competitive landscape for LAB HRA PHARMA, and what generic alternatives to LAB HRA PHARMA drugs are available?
LAB HRA PHARMA has one approved drug.
There are five US patents protecting LAB HRA PHARMA drugs.
There are fifty-three patent family members on LAB HRA PHARMA drugs in twenty-seven countries.
Summary for Lab Hra Pharma
| International Patents: | 53 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Lab Hra Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,962,603 | ➤ Sign Up | ➤ Sign Up | |||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,735,380 | ➤ Sign Up | Y | ➤ Sign Up | ||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,512,745 | ➤ Sign Up | Y | ➤ Sign Up | ||
| Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,426,392 | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LAB HRA PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 30 mg | ➤ Subscribe | 2014-08-13 |
Non-Orange Book US Patents for Lab Hra Pharma
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
International Patents for Lab Hra Pharma Drugs
Similar Applicant Names
Here is a list of applicants with similar names.
